Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial | Synapse
May 9, 2014Open Access
Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial
Key Points
Key points are not available for this paper at this time.
Abstract
Consistency of glycemic control is important to reduce the risks of vascular events and death in type 2 diabetes.